论文部分内容阅读
目的:比较分析难治性宫颈炎患者接受不同方式治疗的临床效果。方法:根据2014年3月至12月我院的114例难治性宫颈炎患者来进行研究分析,将这些患者分成对照组和观察组各57例,对照组使用LEEP手术治疗,观察组使用LEEP手术和重组人干扰素α-2b治疗。两组治疗四周,对临床治疗效果和满意度进行对比分析。结果:治疗4 w后,观察组患者的临床治疗有效率是94.7%,对照组的临床治疗有效率是85.9%,两组的治疗有效率存在统计学差异(P<0.05);观察组患者的血清IL-6、IL-8指标分别为(50.03±0.83)、(51.20±0.44)pg/ml,对照组为(58.66±6.99)、(57.30±6.37)pg/ml,结果具有统计学差异(t=6.027、5.839,P<0.05)。结论:难治性宫颈炎疾病使用LEEP术联合重组人干扰素α-2b进行治疗的效果好,有效率高,临床中可以进行推广使用。
Objective: To comparatively analyze the clinical effect of patients receiving refractory cervicitis in different ways. Methods: According to 114 refractory cervicitis patients in our hospital from March to December in 2014, the patients were divided into control group and observation group, with 57 cases in each group. The control group was treated with LEEP. The observation group was treated with LEEP Surgical and recombinant human interferon alpha-2b therapy. Two groups of four weeks of treatment, the clinical treatment of satisfaction and satisfaction were analyzed. Results: After 4 weeks of treatment, the effective rate of clinical treatment in the observation group was 94.7%, while that in the control group was 85.9%. There was a statistically significant difference between the two groups (P <0.05); in the observation group Serum levels of IL-6 and IL-8 were (50.03 ± 0.83) and (51.20 ± 0.44) pg / ml in the control group and (58.66 ± 6.99 and 57.30 ± 6.37) pg / ml in the control group respectively t = 6.027,5.839, P <0.05). Conclusion: The treatment of refractory cervicitis with LEEP combined with recombinant human interferon α-2b is effective, effective and can be widely used in clinical practice.